Paper of the Month
For the interest and benefit of ESCP members, the Research Committee are going to write a monthly short report on a significant colorectal article that has been published in the last six months.
These summaries should provide an informative read on significant developments that have the potential to help patients. We would welcome your suggestions regarding articles and also your ideas on how this initiative may be developed.
10 November 2025
November's Paper of the Month investigates factors contributing to the difference in higher locoregional recurrence (LRR) observed after total neoadjuvant treatment (TNT) versus chemoradiotherapy in the RAPIDO trial.31 October 2025
October’s Paper of the Month study adds to the data on the effect of structured exercise after adjuvant chemotherapy on disease-free survival in patients with stage II or III colon cancer.23 September 2025
September's Paper of the Month looks at a double-blind, randomised, placebo-controlled trial involving patients with stage I, II, or III rectal cancer or stage II or III colon cancer with somatic alterations in PI3K pathway genes.29 August 2025
August's Paper of the Month study adds to the data looking at associations between the gut microbiome and colorectal cancer (CRC).16 July 2025
This month's paper assessed the noninferior results of chemoradiotherapy and local excision compared with Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer.Page 1 of 15